Wegovy pill vs injection: switching from the pill to the pen
The short answer
Wegovy pill vs injection: the label says patients on 25 mg tablets may switch to the injection, starting 2.4 mg once weekly the day after the last tablet. If the 25 mg tablet isn't tolerated, it says to consider the 1.7 mg injection instead. Paying cash, the pen costs $349 a month and the 25 mg tablet $299.
Key takeaways
- On 25 mg Wegovy tablets? The label allows the 2.4 mg weekly injection, starting the day after your last tablet.
- If the 25 mg tablet isn't tolerated, the label says to consider the 1.7 mg injection. Your prescriber chooses.
- Type 2 diabetes and need more weight reduction on 25 mg tablets? The label also points to 1.7 mg.
- On 1.5 mg, 4 mg or 9 mg tablets? The label gives no pairing. Ask your prescriber.
- Paying cash through NovoCare, the 2.4 mg pen is $349 a month, the 25 mg tablet $299.
What the labels say about switching from Wegovy to Wegovy
In the tablet dosing section, the Wegovy label says that if the 25 mg once-daily tablet maintenance dosage is not tolerated, a switch to the 1.7 mg once-weekly injection can be considered.
If patients do not tolerate the 25 mg once daily maintenance dosage, consider switching to WEGOVY injection 1.7 mg once weekly [see Dosage and Administration (2.5)].
FDA label: Revised: 6/2026 (DailyMed version 19)
The Wegovy label says patients on the 25 mg tablet may switch to the injection, starting 2.4 mg once weekly the day after stopping the tablets. For patients who do not tolerate the 25 mg tablet, it says to consider the 1.7 mg injection.
Patients may switch from WEGOVY 25 mg tablets to WEGOVY injection. The day after discontinuing WEGOVY tablets 25 mg once daily, initiate WEGOVY 2.4 mg subcutaneous injection once weekly. For patients who do not tolerate WEGOVY 25 mg tablets, consider switching to WEGOVY 1.7 mg injection.
FDA label: Revised: 6/2026 (DailyMed version 19)
For patients with type 2 diabetes on the 25 mg Wegovy tablet who need additional weight reduction, the label says to consider switching to the 1.7 mg injection and then following the injection's dosage escalation.
If additional weight reduction is needed in patients with type 2 diabetes mellitus treated with WEGOVY 25 mg tablets, consider switching to WEGOVY 1.7 mg injection and follow the recommended dosage escalation for WEGOVY injection [see Dosage and Administration (2.2), Use in Specific Populations (8.6), Clinical Pharmacology (12.3)].
FDA label: Revised: 6/2026 (DailyMed version 19)
The Wegovy label notes that some patients with type 2 diabetes may get subtherapeutic semaglutide blood concentrations on the tablets, and says to consider alternatives, including switching to the injection, if response to the tablets is inadequate.
Given the differences in average semaglutide blood concentrations after administration of WEGOVY tablets and WEGOVY injection, and the higher variability in semaglutide blood concentrations after administration of WEGOVY tablets in all patient populations, some patients with type 2 diabetes taking WEGOVY tablets may experience subtherapeutic semaglutide blood concentrations. In patients with type 2 diabetes with an inadequate response to WEGOVY tablets, consider alternative therapies, including switching to WEGOVY injection [see Dosage and Administration (2.5)].
FDA label: Revised: 6/2026 (DailyMed version 19)
| How you pay | Per fill | |
|---|---|---|
| Wegovy 25 mg | NovoCare self-pay | $299 |
| Wegovy 0.25 mg | Measured | $248 |
Try other combinations in the switching planner. Switching is a prescriber decision.
Moving from Wegovy tablets to Wegovy injection is one of the switches the FDA label describes in detail. It appears in the label’s section on switching between the two forms, again in the tablet dosing section, and again in the section on specific groups of patients.
What does the label say about going from pill to pen?
There are three statements. Which one fits depends on your reason for switching.
The standard switch. “Patients may switch from WEGOVY 25 mg tablets to WEGOVY injection. The day after discontinuing WEGOVY tablets 25 mg once daily, initiate WEGOVY 2.4 mg subcutaneous injection once weekly.”
The tablet wasn’t tolerated. The same passage goes on: “For patients who do not tolerate WEGOVY 25 mg tablets, consider switching to WEGOVY 1.7 mg injection.” The tablet dosing section repeats this for the 25 mg once-daily maintenance dose (the dose you stay on).
Type 2 diabetes and not enough weight reduction. If patients with type 2 diabetes on 25 mg tablets need more weight reduction, the label says to consider switching to the 1.7 mg injection, then to follow the injection’s recommended step-up schedule. Elsewhere it explains why. Average semaglutide blood levels differ between the tablets and the injection, and they vary more with the tablets. Some patients with type 2 diabetes taking the tablets may have subtherapeutic concentrations (blood levels too low to work as intended). For people in that group who don’t respond well enough, it says to consider other treatments, including the injection.
All three statements start from the 25 mg tablet. The label gives no pairing for someone still on 1.5 mg, 4 mg or 9 mg. In that case the injection’s own schedule begins at 0.25 mg once weekly, and what your prescriber does with that is their decision.
Learning the injection
If you’ve only taken the pill, the pen is new. The label says to inject under the skin of the abdomen, thigh or upper arm, on the same day each week, at any time of day, with or without meals. Use a different injection spot each time. The morning empty-stomach routine and the 30-minute wait that came with the tablets don’t apply to the injection.
Single-dose pens come four to a carton, and you use each one once. Store them in the refrigerator. Before the cap comes off, a pen can be kept between 46°F and 86°F for up to 28 days. Used pens go into an FDA-cleared sharps disposal container, not the household trash. Ask your pharmacist or prescriber to show you the pen before your first dose.
What it costs
NovoCare self-pay prices are:
- 25 mg tablets: $299 a month (one bottle of 30).
- 1.7 mg or 2.4 mg pens: $349 a month (one box of 4 pens).
Over a year at a single dose, that’s $3,588 for the tablet and $4,537 for the 2.4 mg pen. The pen’s lower new-patient price only covers the 0.25 mg and 0.5 mg strengths, and those aren’t the doses the label names for this switch. Every way to buy is on the Wegovy cost page.
Coverage
The switch stays within one brand, but check that your plan covers the pen, and whether it needs its own prior authorization (the plan’s approval before it pays). If your commercial insurance covers it, the Wegovy savings offer brings either form down to as little as $25. On the Medicare GLP-1 Bridge, Wegovy injection and tablets are both covered at $50, and an approval covers refills and dose changes.
The injection also has approved uses the tablets don’t, MASH among them. If your prescriber is changing your form for that reason, the use written on the prescription may change too, and the coverage rules with it.
What to settle with your prescriber
- Which label statement fits you: the standard switch to 2.4 mg, or 1.7 mg because of tolerability or type 2 diabetes.
- The date of your last tablet, since the label starts the injection the next day.
- Which injection form you’ll get. The label says patients should be trained on the specific form they’re given.
- If you have type 2 diabetes, whether the change affects your other blood sugar medicines.
For the other direction, see Wegovy pen to Wegovy pill. The switching planner shows these statements with their label source.
Frequently asked questions
What injection dose do you start after the Wegovy 25 mg pill?
The label says to start Wegovy 2.4 mg by injection once weekly, the day after stopping the 25 mg once-daily tablet. For patients who don't tolerate the 25 mg tablet, it says to consider the 1.7 mg injection. Those are the only two injection doses the label names for this switch, and your prescriber chooses between them.
How soon after my last Wegovy pill can I inject?
The label's timing is the next day. The day after you stop the 25 mg tablets, you start the once-weekly injection. That's different from the other direction, where the tablet starts one week after the last injection. After that, the label says to give the injection on the same day each week.
Why would someone switch from the Wegovy pill to the pen?
The label names three situations: a general switch from the 25 mg tablet, not tolerating the 25 mg tablet, and people with type 2 diabetes who need more weight reduction or don't respond well enough to the tablets. It notes that semaglutide blood levels vary more with the tablets, and that some patients with type 2 diabetes may have levels too low to work as intended.
Does the Wegovy pen cost more than the pill?
On NovoCare's self-pay prices, yes, at maintenance doses. The 1.7 mg and 2.4 mg pens are $349 a month, and the 25 mg tablet is $299. The $199 introductory pen price covers only 0.25 mg and 0.5 mg fills for people new to the offer, so it doesn't apply to a 1.7 mg or 2.4 mg prescription.
Sources (12)
- 1.FDA label (DailyMed): Wegovy prescribing information, section 2.5
“The day after discontinuing WEGOVY tablets 25 mg once daily, initiate WEGOVY 2.4 mg subcutaneous injection once weekly.”
- 2.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Administer WEGOVY injection once weekly, on the same day each week, at any time of day, with or without meals.”
- 3.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Inject WEGOVY subcutaneously in the abdomen, thigh, or upper arm. The time of day and the injection site can be changed without the need for a dosage modification.”
- 4.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Rotate injection sites with each dose.”
- 5.FDA label (DailyMed): Wegovy prescribing information, section 16
“Store the WEGOVY prefilled single-dose pen or single-dose syringe in the refrigerator from 2°C to 8°C (36°F to 46°F). If needed, prior to the pen or syringe cap removal, the pen can be kept from 8°C to 30°C (46°F to 86°F) up to 28 days.”
- 6.FDA label (DailyMed): Wegovy prescribing information, Instructions for Use (single-dose pen)
“Your WEGOVY pen is for 1 time use only. The WEGOVY pen is for subcutaneous (under the skin) use only.”
- 7.FDA label (DailyMed): Wegovy prescribing information, Instructions for Use (single-dose pen)
“Put the used WEGOVY pen in an FDA-cleared sharps disposal container right away after use. Do not throw away (dispose of) the pen in your household trash.”
- 8.FDA label (DailyMed): Wegovy prescribing information, section 16
“WEGOVY injection is a clear, colorless solution available in cartons containing 4 single-dose pens, 4 single-dose syringes with integrated needles, or 1 single-patient-use pen (WEGOVY FlexTouch) as follows:”
- 9.
- 10.
- 11.
- 12.
Related pages
- What is Wegovy? Uses, doses, pill and pen, and cost
- Wegovy cost: pen and pill prices with and without insurance
- Wegovy pill vs injection: switching from the pen to the pill
- Switching GLP-1 medications: what the labels say
- Switching planner
- Wegovy for heart disease: the approved use, the trial behind it and who pays
